American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th
edn) . American
Ten Have, M, Lorsheyd, J, Bijl, R, Osterthun, P. Annual Report Mental Health Care [in Dutch].
Giesen-Bloo, J, van Dyck, R, Spinhoven, P, van Tilburg, W, Dirksen, C, van Asselt, T, Kremers, I, Nadort, M, Arntz, A. Outpatient psychotherapy for borderline personality
disorder: randomized trial of schema-focused therapy vs
transference-focused psychotherapy. Arch Gen
2006; 63: 649–58.
Linehan, MM, Armstrong, HE, Suarez, A, Allmon, D, Heard, HL. Cognitive-behavioral treatment of chronically
parasuicidal borderline patients. Arch Gen
1991; 48: 1060–4.
Van Asselt, ADI, Dirksen, CD, Arntz, A, Severens, JL. The cost of borderline personality disorder:
societal cost of illness in BPD-patients. Eur
2007; 22: 354–61.
Goossens, ME, Rutten-van Molken, MP, Vlaeyen, JW, van der Linden, SM. The cost diary: a method to measure direct and
indirect costs in cost-effectiveness research. J
2000; 53: 688–95.
Van den Brink, M, van den Hout, WB, Stiggelbout, AM, Putter, H, van de Velde, CJ, Kievit, J. Self-reports of health-care utilization: diary or
Int J Technol Assess Health Care
Severens, JL, Mulder, J, Laheij, RJ, Verbeek, AL. Precision and accuracy in measuring absence from
work as a basis for calculating productivity costs in The
Netherlands. Soc Sci Med
2000; 51: 243–9.
Van den Berg, B, Brouwer, WB, Koopmanschap, MA. Economic valuation of informal care. An overview of
methods and applications. Eur J Health
Oostenbrink, JB, Bouwmans, CAM, Koopmanschap, MA, Rutten, FF. Manual for Cost Research. Methods and Unit Prices for
Economic Evaluations in Health Care [in Dutch].
College voor Zorgverzekeringen,
Dutch Health Insurance Board. Pharmacotherapeutic
Compass [in Dutch]. Amstelveen,
Rice, DP, Cooper, BS. The economic value of human life.
Am J Public Health Nations Health
1967; 57: 1954–66.
Arntz, A, van den Hoorn, M, Cornelis, J, Verheul, R, van den Bosch, WM, de Bie, AJ. Reliability and validity of the borderline
personality disorder severity index. J Personal
Brooks, R. EuroQol: the current state of play.
Dolan, P. Modeling valuations for EuroQol health
states. Med Care
1997; 35: 1095–108.
Briggs, AH, Wonderling, DE, Mooney, CZ. Pulling cost-effectiveness analysis up by its
bootstraps: a non-parametric approach to confidence interval
estimation. Health Econ
1997; 6: 327–40.
Efron, B, Tibshirani, RJ. An Introduction to the Bootstrap.
Chapman & Hall,
Van Hout, BA, Al, MJ, Gordon, GS, Rutten, FF. Costs, effects and C/E-ratios alongside a clinical
trial. Health Econ
1994; 3: 309–19.
Manca, A, Hawkins, N, Sculpher, MJ. Estimating mean QALYs in trial-based
cost-effectiveness analysis: the importance of controlling for baseline
utility. Health Econ
2005; 14: 487–96.
Marra, CA, Woolcott, JC, Kopec, JA, Shojania, K, Offer, R, Brazier, JE, Esdaile, JM, Anis, AH. A comparison of generic, indirect utility measures
(the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments
(the RAQoL and the HAQ) in rheumatoid arthritis.
Soc Sci Med
2005; 60: 1571–82.
Gyrd-Hansen, D. Willingness to pay for a QALY.
2003; 12: 1049–60.
King, JT, Tsevat, J, Lave, JR, Roberts, MS. Willingness to pay for a quality-adjusted life year:
implications for societal health care resource
allocation. Med Decis Making
2005; 25: 667–77.
Laupacis, A, Feeny, D, Detsky, AS, Tugwell, PX. How attractive does a new technology have to be to
warrant adoption and utilization? Tentative guidelines for using clinical
and economic evaluations. CMAJ
1992; 146: 473–81.
Devlin, N, Parkin, D. Does NICE have a cost-effectiveness threshold and
what other factors influence its decisions? A binary choice
analysis. Health Econ
2004; 13: 437–52.
Council for Public Health and Health Care. Sensible
and Sustainable Care [in Dutch]. Den
Hayhurst, H, Palmer, S, Abbott, R, Johnson, T, Scott, J. Measuring health-related quality of life in bipolar
disorder: relationship of the EuroQol (EQ-5D) to condition-specific
measures. Qual Life Res
2006; 15: 1271–80.
Sapin, C, Fantino, B, Nowicki, ML, Kind, P. Usefulness of EQ-5D in assessing health status in
primary care patients with major depressive disorder.
Health Qual Life Outcomes
2004; 2: 20.
Van de Willige, G, Wiersma, D, Nienhuis, FJ, Jenner, JA. Changes in quality of life in chronic psychiatric
patients: a comparison between EuroQol (EQ-5D) and
WHOQoL. Qual Life Res
2005; 14: 441–51.
Prieto, L, Sacristan, JA, Hormaechea, JA, Casado, A, Badia, X, Gomez, JC. Psychometric validation of a generic health-related
quality of life measure (EQ-5D) in a sample of schizophrenic
patients. Curr Med Res Opin
2004; 20: 827–35.
Oostenbrink, JB, Al, MJ. The analysis of incomplete cost data due to
dropout. Health Econ
2005; 14: 763–76.
Rubin, DB, Schenker, N. Multiple imputation in health-care databases: an
overview and some applications. Stat Med
1992; 10: 585–98.
Sculpher, MJ, Claxton, K, Drummond, M, McCabe, C. Whither trial-based economic evaluation for health
care decision making?
2006; 15: 677–87.
Barrett, B, Byford, S, Knapp, M. Evidence of cost-effective treatments for
depression: a systematic review. J Affect